The medical writing market has seen considerable growth due to a variety of factors.
•In recent times, the market size for medical writing has seen significant expansion. Forecasts indicate an increase from $3.83 billion in 2024 to $4.25 billion in 2025, with a compound annual growth rate (CAGR) of 10.9%.
This escalating growth during the historic period can be credited to the surge in pharmaceutical research and development, the rising intricacy of drugs and therapies, a growing need for regulatory writing, the imperative for precise and compliant scientific documentation, and the enlargement of clinical trials.
The medical writing market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for medical writing is projected to experience a swift expansion in the coming years, reaching $6.33 billion by 2029, with a compound annual growth rate (CAGR) of 10.5%.
Factors contributing to this growth during the forecasted period include the digital revolution in the healthcare sector, the rising wave of remote working and virtual collaboration in medical writing, the integration of patient feedback into medical writing, and the advent of customized medicine. Other contributing factors are an increase in clinical research outsourcing, patient-focused communication, and the incorporation of real-world data into publications. The forecast period will also see major trends such as technological development, the growing application of artificial intelligence and machine learning in medical writing, collaborations among medical writing agencies, technology vendors, and pharmaceutical corporations, and improvements in digital tools and platforms that have optimized medical writing.
The growth of the medical writing market is forecasted to surge due to the escalating evolution of novel drugs. These novel drugs, which are unapproved or unmarketed pharmaceutical substances used for healing purposes, rely on medical writing to succeed. By furnishing necessary strategies and methods essential for the paperwork involved in drug development, along with information about drug research and information technology, medical writing plays a crucial role. For example, the Food and Drug Administration, a federal agency based in the United States, reported in January 2023 that the Center for Drug Evaluation and Research (CDER) gave approval for 37 novel drugs in 2022, none of which had received previous approval or were marketed in the United States. 54% of those drugs, which equates to 20, received approval in the same year. Thus, the evolving development of novel drugs fuels the expansion of the medical writing market.
The medical writing market covered in this report is segmented –
1) By Type: Clinical Writing, Regulatory Writing, Scientific Writing, Other Types
2) By Application: Medical Journalism, Medical Education, Medico marketing, Other Applications
3) By End-Use: Pharmaceutical Companies, CRO (Contract Research Organization), Other End-Users
Subsegments:
1) By Clinical Writing: Clinical Study Protocols, Clinical Study Reports, Informed Consent Forms
2) By Regulatory Writing: Investigational New Drug (IND) Applications, New Drug Applications (NDA), Biologics License Applications (BLA)
3) By Scientific Writing: Manuscripts For Publication, Abstracts And Posters, Literature Reviews
4) By Other Types: Medical marketing Writing, Educational Materials, Medical Grant Proposals
The trend of product innovation is swiftly gaining traction in the medical writing market. Major corporations in this field are focusing on developing novel products to bolster their market position. As an example, in September 2023, Nuance Communications Inc., a software firm based in the US, introduced the Dragon Ambient eXperience (DAX) Copilot. This AI software employs conversational, ambient, and generative AI to automate the clinical documentation process. The DAX Copilot assists doctors in optimizing their documentation workflow, boosting clinical efficiency and helping to mitigate burnout through time freed for patient care. The solution not only accelerates the creation of more precise medical records but also allows health practitioners to concentrate on delivering superior care and boosting their total productivity.
Major companies operating in the medical writing market include:
• Cardinal Health Inc.
• Merck and Co.Inc.
• AbbVie Inc.
• Abbott Laboratories
• Medtronic Plc.
• Labcorp Drug Development Inc.
• IQVIA Holdings Inc.
• Icon Plc.
• Parexel International Corporation
• Syneos Health
• Ashfield Healthcare Limited
• Indegene Pvt. Ltd
• UDG Healthcare Plc.
• Evidera
• Certara Inc.
• MMS Holdings Inc.
• Freyr Solutions
• Cactus Communication Ltd.
• Omics International Pvt Ltd.
• Quanticate International limited
• Inclin Inc.
• Criterium Inc.
• Aptitude Health.
• Siro Clinpharm Private Limited
• ProScribe Medical Communications
• Pegasus Knowledge Solutions Inc.
• Cognibrain
• Scientific Communications Group
• InkLab Medical Communications
• Trilogy Writing and Consulting GmBH
North America was the largest region in the medical writing market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the medical writing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.